BGEFX
Price
$14.05
Change
-$0.17 (-1.20%)
Updated
Feb 21 closing price
Net Assets
3.34B
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

BGEFX vs RERBX

Header iconBGEFX vs RERBX Comparison
Open Charts BGEFX vs RERBXBanner chart's image
Baillie Gifford International Growth 4
Price$14.05
Change-$0.17 (-1.20%)
VolumeN/A
Net Assets3.34B
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
BGEFX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BGEFX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGEFX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. BGEFX (3.34B). RERBX pays higher dividends than BGEFX: RERBX (1.00) vs BGEFX (0.43). BGEFX was incepted earlier than RERBX: BGEFX (10 years) vs RERBX (23 years). RERBX is a more actively managed with annual turnover of: 34.00 vs. BGEFX (12.00). RERBX has a lower initial minimum investment than BGEFX: RERBX (250) vs BGEFX (200000000). BGEFX annual gain was more profitable for investors over the last year : 8.34 vs. RERBX (0.62). RERBX return over 5 years is better than : 4.32 vs. BGEFX (-1.93).
BGEFXRERBXBGEFX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD11.7776.549180%
Front LoadN/AN/A-
Min. Initial Investment20000000025080,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.34B131B3%
Annual Yield % from dividends0.431.0043%
Returns for 1 year8.340.621,349%
Returns for 3 years5.10-0.32-1,614%
Returns for 5 years-1.934.32-45%
Returns for 10 years36.0715.57232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences